BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls

Cancer Epidemiology

Volumn 36, Issue 3, 2012, Pages

  Bosviel, Rémy ^a,b,c   Garcia, Stéphane ^a,b,c   Lavediaux, Guillaume ^a,b,c   Michard, Emilie ^a,b,c   Dravers, Marine ^a,b,c   Kwiatkowski, Fabrice ^a,b,c   Bignon, Yves Jean ^a,b,c   Bernard Gallon, Dominique J ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

BRCA1; Breast cancer; DNA methylation

Indexed keywords

BRCA1 PROTEIN; DNA; ESTROGEN RECEPTOR; GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; WAIST HIP RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRCA1 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENOMICS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; RISK FACTORS; WAIST-HIP RATIO;

EID: 84860699837     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.02.001     Document Type: Article

References (28)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266(5182):66-71.
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378(6559):789-792.
3. Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997, 57(16):3347-3350.
4. Esteller M., Silva J.M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E., et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000, 92(7):564-569.
5. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349(21):2042-2054.
6. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128(4):683-692.
7. Matros E., Wang Z.C., Lodeiro G., Miron A., Iglehart J.D., Richardson A.L. BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 2005, 91(2):179-186.
8. Rice J.C., Massey-Brown K.S., Futscher B.W. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 1998, 17(14):1807-1812.
9. Rice J.C., Ozcelik H., Maxeiner P., Andrulis I., Futscher B.W. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 2000, 21(9):1761-1765.
10. Wei M., Grushko T.A., Dignam J., Hagos F., Nanda R., Sveen L., et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 2005, 65(23):10692-10699.
11. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447(7143):433-440.
12. Choi J.Y., James S.R., Link P.A., McCann S.E., Hong C.C., Davis W., et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009, 30(11):1889-1897.
13. Pal R., Srivastava N., Chopra R., Gochhait S., Gupta P., Prakash N., et al. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer 2010, 9:303.
14. Widschwendter M., Apostolidou S., Raum E., Rothenbacher D., Fiegl H., Menon U., et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008, 3(7):e2656.
15. Bernard-Gallon D., Bosviel R., Delort L., Fontana L., Chamoux A., Rabiau N., et al. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 2008, 7:36.
16. Delort L., Kwiatkowski F., Chalabi N., Satih S., Bignon Y.J., Bernard-Gallon D.J. Risk factors for early age at breast cancer onset - the " COSA program" population-based study. Anticancer Res 2007, 27(2):1087-1094.
17. Delort L., Satih S., Kwiatkowski F., Bignon Y.J., Bernard-Gallon D.J. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms. Nutr Cancer 2010, 62(2):243-251.
18. Bosviel R., Michard E., Lavediaux G., Kwiatkowski F., Bignon Y.J., Bernard-Gallon D.J. Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls. Clin Chim Acta 2011, 412(15-16):1472-1475.
19. Zeschnigk M., Bohringer S., Price E.A., Onadim Z., Masshofer L., Lohmann D.R. A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res 2004, 32(16):e125.
20. de Jong M.M., Nolte I.M., te Meerman G.J., van der Graaf W.T., Oosterwijk J.C., Kleibeuker J.H., et al. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 2002, 39(4):225-242.
21. Snell C., Krypuy M., Wong E.M., Loughrey M.B., Dobrovic A. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 2008, 10(1):R12.
22. Iwamoto T., Yamamoto N., Taguchi T., Tamaki Y., Noguchi S. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res Treat 2010, 129(1):69-77.
23. Jing F., Zhang J., Tao J., Zhou Y., Jun L., Tang X., et al. Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3σ in serum of sporadic breast cancer patients. Onkologie 2007, 30:14-19.
24. Mirza S., Sharma G., Prasad C.P., Parshad R., Srivastava A., Gupta S.D., et al. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 2007, 81:280-287.
25. Sharma G., Mirza S., Parshad R., Srivastava A., Gupta S.D., Pandya P., et al. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci 2010, 87:83-91.
26. Li Y., Zhu J., Tian G., Li N., Li Q., Ye M., et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010, 8(11):e1000533.
27. Al-Moundhri M.S., Al-Nabhani M., Tarantini L., Baccarelli A., Rusiecki J.A. The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma. PLoS One 2010, 5(12):e15585.
28. Radpour R., Barekati Z., Kohler C., Lv Q., Burki N., Diesch C., et al. Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One 2011, 6(1):e16080.